Michael Untch

Researcher Next ID · RN-001997

Researcher · Biochemistry, Genetics and Molecular Biology

Berlin, Germany

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Breast Cancer Treatment Studies

HER2/EGFR in Cancer Research

Cancer Treatment and Pharmacology

Advanced Breast Cancer Therapies

Cancer Genomics and Diagnostics

Pembrolizumab for Early Triple-Negative Breast Cancer
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1910549
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(13)62422-8
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt303
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.38.8595
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa052306

No projects listed.